Position in GNLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,592
-$196,336 QoQ
Shares Held
17,600
-67.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OMERS ADMINISTRATION Corp holds $62,656,803 across 85 Biotechnology names. GNLX ranks #83 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,797 | $8,393,612 | |
| 2 | TECH |
BIO-TECHNE Corp
|
141,443 | $7,391,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,179 | $6,319,422 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
73,789 | $4,768,983 | |
| 5 | INCY |
Incyte Corp
|
41,083 | $3,866,731 | |
| 6 | RPRX |
Royalty Pharma plc
|
79,307 | $3,804,356 | |
| 7 | EXEL |
Exelixis, Inc.
|
88,362 | $3,789,846 | |
| 8 | IMUX |
Immunic, Inc.
|
168,300 | $1,868,130 |
All Filings in GNLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,592 | 17,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $238,928 | 54,800 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $215,190 | 79,700 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||